{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-005559","form_type":"8-K","ticker":"RNXT","cik":"0001574094","company_name":"RenovoRx, Inc.","filed_at":"2025-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.043574+00:00","generated_at":"2026-05-27T00:01:42.120661+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"RenovoRx prices $12.1M underwritten public offering of 11.5M shares at $1.05 per share","bullets":["Offering of 11,523,810 shares at $1.05/share; gross proceeds ~$12.1M, net ~$10.9M after underwriting discounts and expenses.","Closing expected February 10, 2025; underwriter warrants issued for 576,191 shares at $1.21/share.","Proceeds to fund Phase III TIGeR-PaC study and commercial activities for RenovoCath device.","Titan Partners Group acted as sole bookrunner for the firm commitment offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-005559","json":"https://secwatch.observer/filing/0001493152-25-005559.json","markdown":"https://secwatch.observer/filing/0001493152-25-005559.md","text":"https://secwatch.observer/filing/0001493152-25-005559.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574094/000149315225005559/0001493152-25-005559-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574094/000149315225005559/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:01:42.120661+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}